Tata Hospital with Bangalore lab develop India’s first oral suspension for leukemia, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

Doctors from Mumbai’s Tata Memorial Centre in collaboration with IDRS Labs in Bangalore have developed India’s first and only chemotherapy drug, 6-mercaptopurine (6-MP), to be available in a syrup form. This drug is crucial to combat Acute Lymphoblastic Leukemia (ALL), the commonest form of blood cancer affecting children., Doctors from Mumbai’s Tata Memorial Centre in collaboration with IDRS Labs in Bangalore have developed India’s first and only chemotherapy drug, 6-mercaptopurine (6-MP), to be available in a syrup form. This drug is crucial to combat Acute Lymphoblastic Leukemia (ALL), the commonest form of blood cancer affecting children., , Read More